Abstract
In the last years there have been many developments regarding corneal diseases and treatments.
In this chapter we will discuss some of the most important achievements in this field.
A novel therapy for neurotrophic keratopathy has been recently developed. Moreover, newer strategies have been outlined to identify and treat infectious keratitis. The diagnosis and management of dry eye has also evolved. However, the most revolutionary change was probably in corneal transplantation. Nowadays in most cases it is no longer necessary to perform a penetrating keratoplasty (PK) but it is possible to replace the diseased corneal layer only, performing a lamellar transplant.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dua HS, Said DG, Messmer EM, Rolando M, Benitez-Del-Castillo JM, Hossain PN, et al. Neurotrophic keratopathy. Prog Retin Eye Res. 2018;66:107–31.
Bonini S, Lambiase A, Rama P, Sinigaglia F, Allegretti M, Chao W, et al. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125(9):1332–43.
Vaddavalli PK, Garg P, Sharma S, Sangwan VS, Rao GN, Thomas R. Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis. Ophthalmology. 2011;118(1):29–35.
Inoue T, Ohashi Y. Utility of real-time PCR analysis for appropriate diagnosis for keratitis. Cornea. 2013;32(Suppl 1):S71–6.
Eguchi H, Hotta F, Kuwahara T, Imaohji H, Miyazaki C, Hirose M, et al. Diagnostic approach to ocular infections using various techniques from conventional culture to next-generation sequencing analysis. Cornea. 2017;36(Suppl 1):S46–52.
Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29(1):35–40.
Price MO, Price FW. Corneal cross-linking in the treatment of corneal ulcers. Curr Opin Ophthalmol. 2016;27(3):250–5.
Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of Infectious keratitis. Ophthalmology. 2017;124(11):1678–89.
Richoz O, Gatzioufas Z, Francois P, Schrenzel J, Hafezi F. Impact of fluorescein on the antimicrobial efficacy of photoactivated riboflavin in corneal collagen cross-linking. J Refract Surg. 2013;29(12):842–5.
Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2018;29(1):19–32.
Hsu J, Gerstenblith AT, Garg SJ, Vander JF. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 2014;157(3):514–8.e1.
Isenberg SJ, Apt L, Valenton M, Sharma S, Garg P, Thomas PA, et al. Prospective, randomized clinical trial of povidone-iodine 1.25% solution versus topical antibiotics for treatment of bacterial keratitis. Am J Ophthalmol. 2017;176:244–53.
Yamasaki K, Saito F, Ota R, Kilvington S. Antimicrobial efficacy of a novel povidone iodine contact lens disinfection system. Cont Lens Anterior Eye. 2018;41(3):277–81.
Cho P, Reyes S, Boost MV. Microbiocidal characterization of a novel povidone-iodine based rigid contact lens disinfecting solution. Cont Lens Anterior Eye. 2018;41(6):542–6.
Abidi A, Shukla P, Ahmad A. Lifitegrast: a novel drug for treatment of dry eye disease. J Pharmacol Pharmacother. 2016;7(4):194–8.
Chan CC, Prokopich CL. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: overview of clinical trial program. J Pharm Pharm Sci. 2019;22(1):49–56.
Cohn GS, Corbett D, Tenen A, Coroneo M, McAlister J, Craig JP, et al. Randomized, controlled, double-masked, multicenter, pilot study evaluating safety and efficacy of intranasal neurostimulation for dry eye disease. Invest Ophthalmol Vis Sci. 2019;60(1):147–53.
Arenas E, Esquenazi S, Anwar M, Terry M. Lamellar corneal transplantation. Surv Ophthalmol. 2012;57(6):510–29.
McAllum PJ, Segev F, Herzig S, Rootman DS. Deep anterior lamellar keratoplasty for post-LASIK ectasia. Cornea. 2007;26(4):507–11.
Ramamurthi S, Cornish KS, Steeples L, Ramaesh K. Deep anterior lamellar keratoplasty on a previously failed full-thickness graft. Cornea. 2009;28(4):456–7.
Lake D, Hamada S, Khan S, Daya SM. Deep anterior lamellar keratoplasty over penetrating keratoplasty for host rim thinning and ectasia. Cornea. 2009;28(5):489–92.
Singh G, Singh Bhinder H. Evaluation of therapeutic deep anterior lamellar keratoplasty in acute ocular chemical burns. Eur J Ophthalmol. 2008;18(4):517–28.
Fogla R, Padmanabhan P. Deep anterior lamellar keratoplasty combined with autologous limbal stem cell transplantation in unilateral severe chemical injury. Cornea. 2005;24(4):421–5.
Luengo-Gimeno F, Tan DT, Mehta JS. Evolution of deep anterior lamellar keratoplasty (DALK). Ocul Surf. 2011;9(2):98–110.
Bhatt PR, Lim LT, Ramaesh K. Therapeutic deep lamellar keratoplasty for corneal perforations. Eye (Lond). 2007;21(9):1168–73.
Sarnicola E, Sarnicola C, Sabatino F, Tosi GM, Perri P, Sarnicola V. Early deep anterior lamellar keratoplasty (DALK) for Acanthamoeba keratitis poorly responsive to medical treatment. Cornea. 2016;35(1):1–5.
Sabatino F, Sarnicola E, Sarnicola C, Tosi GM, Perri P, Sarnicola V, et al. Early deep anterior lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment. Eye (Lond). 2017;31:1639–46.
Anwar M, Teichmann KD. Big-bubble technique to bare Descemet’s membrane in anterior lamellar keratoplasty. J Cataract Refract Surg. 2002;28(3):398–403.
Sarnicola E, Sarnicola C, Sabatino F, Tosi GM, Perri P, Sarnicola V. Cannula DALK versus needle DALK for keratoconus. Cornea. 2016;35(12):1508–11.
Sarnicola V, Toro P. Blunt cannula for descemetic deep anterior lamellar keratoplasty. Cornea. 2011;30(8):895–8.
Fournié P, Malecaze F, Coullet J, Arné JL. Variant of the big bubble technique in deep anterior lamellar keratoplasty. J Cataract Refract Surg. 2007;33(3):371–5.
Muftuoglu O, Toro P, Hogan RN, Bowman RW, Cavanagh HD, McCulley JP, et al. Sarnicola air-visco bubble technique in deep anterior lamellar keratoplasty. Cornea. 2013;32(4):527–32.
Feizi S, Javadi MA, Jamali H, Mirbabaee F. Deep anterior lamellar keratoplasty in patients with keratoconus: big-bubble technique. Cornea. 2010;29(2):177–82.
Sarnicola V, Toro P, Sarnicola C, Sarnicola E, Ruggiero A. Long-term graft survival in deep anterior lamellar keratoplasty. Cornea. 2012;31(6):621–6.
Holland EJ, Mannis MJ. Cornea. 4th ed. Amsterdam: Elsevier; 2016.
Deng SX, Lee WB, Hammersmith KM, Kuo AN, Li JY, Shen JF, et al. Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology. 2018;125(2):295–310.
Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea. 2006;25(8):886–9.
Melles GR, Wijdh RH, Nieuwendaal CP. A technique to excise the descemet membrane from a recipient cornea (descemetorhexis). Cornea. 2004;23(3):286–8.
Busin M, Albé E. Does thickness matter: ultrathin Descemet stripping automated endothelial keratoplasty. Curr Opin Ophthalmol. 2014;25(4):312–8.
Cheung AY, Hou JH, Bedard P, Grimes V, Buckman N, Eslani M, et al. Technique for preparing ultrathin and nanothin descemet stripping automated endothelial keratoplasty tissue. Cornea. 2018;37(5):661–6.
Sarnicola V, Millacci C, Sarnicola E, Sarnicola C, Sabatino F, Ruggiero A. Suture pull-through insertion of graft donor in Descemet stripping automated endothelial keratoplasty: results of 4-year follow-up. Taiwan J Ophthalmol. 2015;5(3):114–9.
Price FW, Feng MT, Price MO. Evolution of endothelial keratoplasty: where are we headed? Cornea. 2015;34(Suppl 10):S41–7.
Melles GR, Lander F, Rietveld FJ. Transplantation of Descemet’s membrane carrying viable endothelium through a small scleral incision. Cornea. 2002;21(4):415–8.
Dapena I, Moutsouris K, Droutsas K, Ham L, van Dijk K, Melles GR. Standardized “no-touch” technique for descemet membrane endothelial keratoplasty. Arch Ophthalmol. 2011;129(1):88–94.
Veldman PB, Dye PK, Holiman JD, Mayko ZM, Sáles CS, Straiko MD, et al. The S-stamp in Descemet membrane endothelial keratoplasty safely eliminates upside-down graft implantation. Ophthalmology. 2016;123(1):161–4.
Sarnicola C, Sabatino F, Sarnicola E, Perri P, Cheung AY, Sarnicola V. Cannula-assisted technique to unfold grafts in descemet membrane endothelial keratoplasty. Cornea. 2019;38(3):275–9.
Yoeruek E, Bayyoud T, Hofmann J, Bartz-Schmidt KU. Novel maneuver facilitating Descemet membrane unfolding in the anterior chamber. Cornea. 2013;32(3):370–3.
Liarakos VS, Dapena I, Ham L, van Dijk K, Melles GR. Intraocular graft unfolding techniques in descemet membrane endothelial keratoplasty. JAMA Ophthalmol. 2013;131(1):29–35.
Melles GR, Ong TS, Ververs B, van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea. 2006;25(8):987–90.
Okumura N, Kinoshita S, Koizumi N. The role of Rho kinase inhibitors in corneal endothelial dysfunction. Curr Pharm Des. 2017;23:660–6.
Okumura N, Fujii K, Kagami T, Makiko N, Kitahara M, Kinoshita S, et al. Activation of the Rho/Rho kinase signaling pathway is involved in cell death of corneal endothelium. Invest Ophthalmol Vis Sci. 2016;57(15):6843–51.
Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Tsuchiya H, et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol. 2012;181(1):268–77.
Okumura N, Okazaki Y, Inoue R, Kakutani K, Nakano S, Kinoshita S, et al. Effect of the Rho-associated kinase inhibitor eye drop (Ripasudil) on corneal endothelial wound healing. Invest Ophthalmol Vis Sci. 2016;57(3):1284–92.
Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, et al. Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. N Engl J Med. 2018;378(11):995–1003.
Sarnicola C, Farooq AV, Colby K. Fuchs endothelial corneal dystrophy: update on pathogenesis and future directions. Eye Contact Lens. 2019;45(1):1–10.
Borboli S, Colby K. Mechanisms of disease: Fuchs’ endothelial dystrophy. Ophthalmol Clin N Am. 2002;15(1):17–25.
Moloney G, Petsoglou C, Ball M, Kerdraon Y, Höllhumer R, Spiteri N, et al. Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical Ripasudil. Cornea. 2017;36(6):642–8.
Macsai MS, Shiloach M. Use of topical Rho kinase inhibitors in the treatment of Fuchs dystrophy after descemet stripping only. Cornea. 2019;38(5):529–34.
Liang L, Sheha H, Li J, Tseng SC. Limbal stem cell transplantation: new progresses and challenges. Eye (Lond). 2009;23(10):1946–53.
Atallah MR, Palioura S, Perez VL, Amescua G. Limbal stem cell transplantation: current perspectives. Clin Ophthalmol. 2016;10:593–602.
Kenyon KR, Tseng SC. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989;96(5):709–22; discussion 22-3.
Cheung AY, Sarnicola E, Holland EJ. Long-term ocular surface stability in conjunctival limbal autograft donor eyes. Cornea. 2017;36(9):1031–5.
Sangwan VS, Basu S, MacNeil S, Balasubramanian D. Simple limbal epithelial transplantation (SLET): a novel surgical technique for the treatment of unilateral limbal stem cell deficiency. Br J Ophthalmol. 2012;96(7):931–4.
Amescua G, Atallah M, Nikpoor N, Galor A, Perez VL. Modified simple limbal epithelial transplantation using cryopreserved amniotic membrane for unilateral limbal stem cell deficiency. Am J Ophthalmol. 2014;158(3):469–75.e2.
Croasdale CR, Schwartz GS, Malling JV, Holland EJ. Keratolimbal allograft: recommendations for tissue procurement and preparation by eye banks, and standard surgical technique. Cornea. 1999;18(1):52–8.
Biber JM, Skeens HM, Neff KD, Holland EJ. The cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure. Cornea. 2011;30(7):765–71.
Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med. 2000;343(2):86–93.
Satake Y, Higa K, Tsubota K, Shimazaki J. Long-term outcome of cultivated oral mucosal epithelial sheet transplantation in treatment of total limbal stem cell deficiency. Ophthalmology. 2011;118(8):1524–30.
Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea. 2011;30(11):1187–94.
Pujari S, Siddique SS, Dohlman CH, Chodosh J. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience. Cornea. 2011;30(12):1298–303.
StrampellI B. Osteo-odontokeratoprosthesis. Ann Ottalmol Clin Ocul. 1963;89:1039–44.
Michael R, Charoenrook V, de la Paz MF, Hitzl W, Temprano J, Barraquer RI. Long-term functional and anatomical results of osteo- and osteoodonto-keratoprosthesis. Graefes Arch Clin Exp Ophthalmol. 2008;246(8):1133–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sarnicola, C., Sarnicola, E., Perri, P., Sarnicola, V. (2020). Recent Developments in Cornea and Corneal Transplants. In: Grzybowski, A. (eds) Current Concepts in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-25389-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-25389-9_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25388-2
Online ISBN: 978-3-030-25389-9
eBook Packages: MedicineMedicine (R0)